Lee Fleisher, MD Joins Duke-Margolis as Visiting Fellow

Lee Fleisher, MD Joins Duke-Margolis as Visiting Fellow

Lee Fleisher Headshot

Former CMS Chief Medical Officer to Focus on Coverage and Reimbursement Policies for Drugs and Medical Technologies

 

Lee A. Fleisher, MD, former Chief Medical Officer and Director of the Center for Clinical Standards and Quality at the Centers for Medicare & Medicaid Services (CMS), has joined Duke-Margolis as a Visiting Fellow. 

In this volunteer role, Fleisher will participate and provide expert perspectives to Duke-Margolis efforts and research on:

  • key issues in coverage and reimbursement policies for medical technologies, drugs, gene and cell therapies, and diagnostics,
  • improving the quality of real-world data and evidence to support better care and improved payment methods,
  • improving quality measurement and risk adjustment, and reducing its administrative burdens,
  • enhancing the timeliness and reliability of health care data and response systems for public health emergencies, and for improved monitoring and action on public health priorities more generally, and
  • collaborating on other policy research and development areas of interest related to health care delivery, financing, and the health of the US population.

Currently, Emeritus Professor of Anesthesiology and Critical Care and a Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania Perelman School of Medicine, Fleisher teaches the development of novel ideas and technologies to drive quality and value in health care in the Penn Masters in Healthcare Innovation.

“We are very pleased to have Lee join Duke-Margolis as a Visiting Fellow,” said Mark McClellan, Founding Director of Duke-Margolis. “Lee’s expertise and thought leadership will be important and extremely timely contributions to our ongoing efforts to advance therapeutic coverage and reimbursement policies that will ensure affordable access to the tremendous potential of new drugs and devices for the millions of Americans who need them.” 

The appointment of a Visiting Fellow is reserved for distinguished individuals who, through their collaboration with the Duke-Margolis Center, are deserving of an affiliation because of their contributions to Duke-Margolis health reform initiatives, but do not have any formal academic responsibilities nor do they receive financial support from the University.

“During my tenure at CMS, I had the privilege of participating on several Duke-Margolis Center meetings and learning from their analyses,” said Lee Fleisher.  “I am excited to be joining the Center as a Visiting Fellow to continue this important work”
    
###